Nintedanib in patients with progressive fibrosing interstitial lung diseases-subgroup analyses by interstitial lung disease diagnosis in the INBUILD trial: a randomised, double-blind, placebo-controlled, parallel-group trial.
AU Wells, KR Flaherty, KK Brown, Y Inoue, A Devaraj, L Richeldi, T Moua, B Crestani, WA Wuyts, S Stowasser, M Quaresma, RG Goeldner, INBUILD trial investigators
Research output: Contribution to journal › Article › peer-review
Fingerprint
Dive into the research topics of 'Nintedanib in patients with progressive fibrosing interstitial lung diseases-subgroup analyses by interstitial lung disease diagnosis in the INBUILD trial: a randomised, double-blind, placebo-controlled, parallel-group trial.'. Together they form a unique fingerprint.